Profile

2023

1. Sola P, Garikapati KK, Krishnamurthy PT, Kumari M, Polysorbate 80 surface modified SLNs of formoterol suppress SNCA gene and mitochondrial oxidative stress in mice model of Parkinson’s disease.  Scientific Reports

2. Roy D, Balasubramanian S, Krishnamurthy PT, Sola P, Rymbai E. , Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential. .  Cellular and Molecular Neurobiology.

3. Lamichhane S, Sahariah BJ, Das B, Khatiwara D, Sola P, Adhikari RP, Gogoi B, Alam T. , Herbal Drug Standardization: A Systemic Review. .  Journal of Drug Delivery and Therapeutics.

2022

1. Sola P, Krishnamurthy PT, Kumari M, Byran G, Gangadharappa HV, Garikapati KK, Neuroprotective approaches to halt Parkinson's disease progression. .  Neurochemistry International. 10.1016/j.neuint.2022.105380

2. Kantabathina Hemanth, Kaviarasan Lakshmanan, Kalirajan Rajagopal, Piyongsola and Gowramma Byran, A Review On Biological Activities: 1,3,4-Thiadiazole And Its Derivatives.  Rasayan Journal of Chemistry

2020

1. Piyong Sola, Praveen T. Krishnamurthy, Pavan Kumar Chintamaneni, Sai Kiran S.S Pindiprolu & Mamta Kumari , Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management.  Expert Opinion on Drug Delivery. 10.1080/17425247.2020.1779218

2. Mamta Kumari, Praveen Thaggikuppe Krishnamurthy, Piyong Sola, Targeted Drug Therapy to Overcome Chemoresistance in Triple-Negative Breast Cancer.  Current Cancer Drug Targets

3. Mamta Kumari, Piyong Sola, Praveen T Krishnamurthy, DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment. .  Advanced Pharmaceutical Bulletin

2019

1. Kalyan Roy, Bibek Dahal, Piyongsola, Prasanti Sharma, Gayatri Thapa and Diptendu Bhowmik. , Influence of Etoricoxib on Pharmacokinetics and Pharmacodynamics of Glibenclamide in Rabbits. .  EAS Journal of Pharmacy and Pharmacology.